Costello LC, Franklin RB (2016) A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys 611:100–112. https://doi.org/10.1016/j.abb.2016.04.014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson IM, Pauler DK, Goodman PJ et al (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 Ng per milliliter. New England J Med 350(22):2239–46

Costello LC, Franklin RB (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5:17. https://doi.org/10.1186/1476-4598-5-17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43(3):289–297

Article  PubMed  Google Scholar 

Aaron L, Franco OE, Hayward SW (2016) Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urol Clin North Am 43(3):279–288

Article  PubMed  PubMed Central  Google Scholar 

Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C et al (2015) Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int 115(1):24–31

Article  PubMed  Google Scholar 

Gacci M, Sebastianelli A, Salvi M, De Nunzio C, Vignozzi L, Corona G et al (2017) Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol 17(1):22

Article  PubMed  PubMed Central  Google Scholar 

Sebastianelli A, Gacci M (2018) Current status of the relationship between metabolic syndrome and lower urinary tract symptoms. Eur Urol Focus 4(1):25–27

Article  PubMed  Google Scholar 

Vignozzi L, Rastrelli G, Corona G, Gacci M, Forti G, Maggi M (2014) Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 37(4):313–322

Article  CAS  PubMed  Google Scholar 

Jordan MVC, Lo S-T, Chen S, Preihs C, Chirayil S, Zhang S, Kapur P et al (2016) Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs malignant mouse prostate. Proc Nat Acad Sci 113(37):E5464-71. https://doi.org/10.1073/pnas.1609450113

Article  CAS  Google Scholar 

Khalighinejad P, Parrott D, Jordan VC, Chirayil S, Preihs C, Rofsky NM, Xi Y, Sherry AD (2021) Magnetic resonance imaging detection of glucose-stimulated zinc secretion in the enlarged dog prostate as a potential method for differentiating prostate cancer from benign prostatic hyperplasia. Investig Radiol 56(7):450–57. https://doi.org/10.1097/RLI.0000000000000760

Article  CAS  Google Scholar 

Lo S-T, Parrott D, Jordan MVC, Joseph DB, Strand D, Lo U-G, Lin H, Darehshouri A, Sherry AD (2021) The roles of ZnT1 and ZnT4 in glucose-stimulated zinc secretion in prostate epithelial cells. Mol Imaging Biol 23(2):230–40. https://doi.org/10.1007/s11307-020-01557-x

Article  CAS  PubMed  Google Scholar 

Thapa B, Suh EH, Parrott D, Khalighinejad P, Sharma G, Chirayil S, Sherry AD (2022) Imaging β-cell function using a zinc-responsive MRI contrast agent may identify first responder islets. Front Endocrinol 12:809867. https://www.frontiersin.org/articles/10.3389/fendo.2021.809867

Li D, Chen S, Bellomo EA, Tarasov AI, Kaut C, Rutter GA, Li W-H (2011) Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR). Proc Nat Acad Sci 108(52):21063–68. https://doi.org/10.1073/pnas.1109773109

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Zhang W, Cao Y, Liu Y, Bergmeier S, Chen X (2010) Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms. Cancer Lett 298(2):176–85. https://doi.org/10.1016/j.canlet.2010.07.002

Article  CAS  PubMed  Google Scholar 

Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, Colvin R et al (2012) A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther 11(8):1672–82. https://doi.org/10.1158/1535-7163.MCT-12-0131

Article  CAS  PubMed  Google Scholar 

Vikram A, Jena G (2010) S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats. Biochem Biophys Res Commun 398(2):260–65. https://doi.org/10.1016/j.bbrc.2010.06.070

Article  CAS  PubMed  Google Scholar 

Sharma P, Kumar S (2018) S961, a biosynthetic insulin receptor antagonist, downregulates insulin receptor expression & suppresses the growth of breast cancer cells. Indian J Med Res 147(6):545–551. https://doi.org/10.4103/ijmr.IJMR_403_17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ginja M, Pires MJ, Gonzalo-Orden JM, Seixas F, Correia-Cardoso M, Ferreira R, Fardilha M, Oliveira PA, Faustino-Rocha AI (2019) Anatomy and imaging of rat prostate: practical monitoring in experimental cancer-induced protocols. Diagnostics 9(3):68. https://doi.org/10.3390/diagnostics9030068

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song Y, Elias V, Wong CP, Scrimgeour AG, Ho E (2010) Zinc transporter expression profiles in the rat prostate following alterations in dietary zinc. Biometals : Int J Role Metal Ions Biol, Biochem, Med 23(1):51–58. https://doi.org/10.1007/s10534-009-9266-8

Article  CAS  Google Scholar 

Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, N.Y.) 324(5930):1029–33. https://doi.org/10.1126/science.1160809

De Meyts P (2000) The insulin receptor and its signal transduction network. In: Feingold KR, Anawalt B, Blackman MR et al (eds) Endotext. South Dartmouth (MA): MDText.com, Inc. http://www.ncbi.nlm.nih.gov/books/NBK378978/

Norouzi S, Adulcikas J, Sohal SS, Myers S (2018) Zinc stimulates glucose oxidation and glycemic control by modulating the insulin signaling pathway in human and mouse skeletal muscle cell lines. PLoS ONE 13(1):e0191727. https://doi.org/10.1371/journal.pone.0191727

Rutter GA, Chabosseau P, Bellomo EA, Maret W, Mitchell RK, Hodson DJ, Solomou A, Ming Hu (2016) Intracellular zinc in insulin secretion and action: a determinant of diabetes risk? Proc Nutr Soc 75(1):61–72. https://doi.org/10.1017/S0029665115003237

Article  CAS  PubMed  Google Scholar 

Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y (2014) 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett 355(2):176–83. https://doi.org/10.1016/j.canlet.2014.09.003

Article  CAS  PubMed  Google Scholar 

Halestrap AP, Wilson MC (2012) The monocarboxylate transporter family—role and regulation. IUBMB Life 64(2):109–119. https://doi.org/10.1002/iub.572

Article  CAS  PubMed  Google Scholar 

Fukushima M, Lee SM, Moro N, Hovda DA, Sutton RL (2009) Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury. J Neurotrauma 26(7):1095–1110. https://doi.org/10.1089/neu.2008.0771

Article  PubMed  PubMed Central  Google Scholar 

Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C (2016) Liver glucose metabolism in humans. Biosci Rep 36(6):e00416. https://doi.org/10.1042/BSR20160385

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH (2002) Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim et Biophys Acta (BBA) - Bioenerg, 12th Eur Bioenerg Conf 1555(1–3):14–20. https://doi.org/10.1016/S0005-2728(02)00248-7.

Deng Y, Lu J (2015) Targeting hexokinase 2 in castration-resistant prostate cancer. Mol Cell Oncol 2(3):e974465. https://doi.org/10.4161/23723556.2014.974465

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cortesi M, Fridman E, Volkov A, Shilstein S, Chechik R, Breskin A, Vartsky D et al (2008) Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study. The Prostate 68(9):994–1006. https://doi.org/10.1002/pros.20766

Article  CAS  PubMed  Google Scholar 

Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D et al (2016) PI-RADS prostate imaging – reporting and data system: 2015, version 2. Eur Urol 69(1):16–40. https://doi.org/10.1016/j.eururo.2015.08.052

Article  PubMed  Google Scholar